NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:25
NeurAxis Gross Profit Margin (Quarterly) : 85.87% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.87% |
| March 31, 2026 | 86.42% |
| December 31, 2025 | 85.37% |
| September 30, 2025 | 83.30% |
| June 30, 2025 | 83.59% |
| March 31, 2025 | 84.43% |
| December 31, 2024 | 86.19% |
| September 30, 2024 | 85.45% |
| June 30, 2024 | 87.98% |
| Date | Value |
|---|---|
| March 31, 2024 | 88.40% |
| December 31, 2023 | 86.38% |
| September 30, 2023 | 85.91% |
| June 30, 2023 | 89.50% |
| March 31, 2023 | 88.09% |
| December 31, 2022 | 87.73% |
| June 30, 2022 | 88.43% |
| March 31, 2022 | 90.24% |
| December 31, 2021 | 85.13% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 50.36% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.30% |
| AtriCure, Inc. | 76.80% |
| Baxter International, Inc. | 33.30% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -171.2% |
| Return on Assets | -101.0% |
| Return on Invested Capital | -157.6% |
| Profit Margin (Quarterly) | -108.1% |
| Operating Margin (Quarterly) | -110.2% |
| Return on Net Operating Assets | -671.9% |